The Zika virus is being portrayed as an incurable new virus by the media, but pharmaceutical companies Merck and Novartis patented cures for the Zika virus in 2006 and 2008 respectively. Both companies are, therefore, positioned to make a huge profit from the decision of WHO to declare Zika a public health emergency, triggering Zika vaccine and drug programmes.
A search of the United States Patent and Trademark Office database shows that Merck is named as the assignee of the patent of a cure for the Zika virus, ie as the person who holds the whole interest of a patent, invented by others.
The date the application was filed is given as October 5, 2006.
Novartis is also named in a patent for a Zika cure, dated February 7, 2008.